A review on the sustainability of thermal treatment for contaminated soils.

Sustainable remediation is a goal in the remediation industry. Thermal treatment can remediate contaminated sites quickly and reliably, but its energy-intensive nature and potential to damage soil properties make it seemingly not sustainable. This review evaluates the potential for thermal treatment to become a sustainable remediation technology based on a comprehensive analysis of the scientific literature. The fundamentals, advantages, and limitations of single thermal treatment technologies are summarized. The compatibility and advantages of thermal treatment coupled with thermal, physicochemical, or biological technologies are reviewed. The results suggest that ingeniously designed coupled technologies can improve the availability and removal efficiency of contaminant, suppress the production of toxic byproduct, and reduce the required heating temperature and energy input. The sustainability of thermal treatment is then discussed from the perspectives of energy efficiency and land reuse. Approaches for improving energy efficiency include applying solar energy-based technologies, smoldering-based technologies, and coupled technologies. For land reuse, heating below 250 °C has negligible adverse impacts on most soil properties, and can increase nutrient availability and release dissolved organic carbon to support the growth of microorganisms and plants. Heating above 250 °C can significantly reduce soil organic matter and clay content, which decreases the soil cation exchange capacity and water holding capacity, and consequently damages the soil fertility. Some restoration strategies are also proposed for the recovery of soil quality. In addition, thermally remediated soil is considered to be a good candidate as an engineering medium for construction. This review concludes with an outlook of future research efforts that will further shift thermal treatment toward sustainable remediation.

Anticancer drugs from traditional toxic Chinese medicines.

Many anticancer drugs are obtained from natural sources. Nature produces a variety of toxic compounds, which are often used as anticancer drugs. Up to now, there are at least 120 species of poisonous botanicals, animals and minerals, of which more than half have been found to possess significant anticancer properties. In spite of their clinical toxicity, they exhibit pharmacological effects and have been used as important traditional Chinese medicines for the different stages of cancer. The article reviews many structures such as alkaloids of Camptotheca acuminata, Catharanthus roseus and Cephalotaxus fortunei, lignans of Dysosma versipellis and Podophyllum emodi, ketones of Garcinia hanburyi, terpenoids of Mylabris and Ginkgo biloba, diterpenoids of Tripterygium wilfordii, Euphorbia fischeriana, Euphorbia lathyris, Euphorbia kansui, Daphne genkwa, Pseudolarix kaempferi and Brucea javanica, triterpenoids of Melia toosendan, steroids of Periploca sepium, Paris polyphylla and Venenum Bufonis, and arsenic compounds including Arsenicum and Realgar. By comparing their related phytochemistry, toxic effects and the recent advances in understanding the mechanisms of action, this review puts forward some ideals and examples about how to increase antitumour activity and/or reduce the side effects experienced with Chinese medicine.

[Research progress in medicinal plant cell suspension culture].

China consumes and exports traditional Chinese medicinal resources the most in the world. However, we cannot anchor our hope on field production of traditional Chinese medicinal materials and their active ingredients, due to limited land resources. Therefore, the development of biotechnology is of great importance for China to solve the problem of traditional Chinese medicinal resources. Plant cell culture is an important approach for the sustainable development of precious medicinal resources. This essary summarizes the optimization of conditions for medicinal plant cell culture, the regulation of secondary metabolic pathways and cell bioreactor culture, and realizes that the authentic commercial production of more medicinal plants requires efforts from all aspects.